Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI® (sparsentan) in FSGS — Neutral
TVTX Business Wire — January 13, 2026SAN DIEGO--(BUSINESS WIRE)---- $TVTX--Travere Therapeutics, Inc., (Nasdaq: TVTX) announced that today the U.S. Food and Drug Administration (FDA) has extended the review timeline of its supplemental New Drug Application (sNDA) for FILSPARI® (sparsentan) in focal segmental glomerulosclerosis (FSGS). The new Prescription Drug User Fee Act (PDUFA) target action date is April 13, 2026. The extension follows the recent submission of responses requested by the FDA to further characterize the clinical benefit o.
Boeing reports most annual aircraft deliveries since 2018 — Positive
BA Proactive Investors — January 13, 2026Boeing Co (NYSE:BA, XETRA:BCO) reported its major program deliveries for the fourth quarter and full year of 2025, showing gains across both its commercial and defense operations. For the full year, Boeing delivered 600 commercial aircraft, the company's highest annual total since 2018 and a significant increase from 348 units in 2024.
Akebia Post-Selloff: Revenue Dynamics And Upcoming Catalysts — Neutral
AKBA Seeking Alpha — January 13, 2026Akebia Post-Selloff: Revenue Dynamics And Upcoming Catalysts
VRT's Robust Portfolio Fuels Revenue Growth: More Upside Ahead? — Positive
VRT Zacks Investment Research — January 13, 2026Vertiv's broad data center portfolio and focus on innovation are driving growth momentum, despite competition heating up across the industry.
HDFC Bank: A Mixed View Of Business Update And Earnings Preview — Positive
HDB Seeking Alpha — January 13, 2026I continue to rate HDFC Bank as a 'Hold,' following my assessment of its recently announced operational update and preview of the upcoming results. HDB's loans expanded at a slower pace than its key Indian banking peers in 3QFY26, according to its latest quarterly business update. But I anticipate that its 3rd quarter earnings will still grow at a similar high-single-digit to low-teens level, similar to Q2, thanks to net interest margin improvement.
Trade Tracker: Stephanie Link sells the INDA and buys the EWZ — Neutral
INDA EWZ CNBC Television — January 13, 2026Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to detail her latest portfolio moves outside of the U.S.
LATAM Airlines December 2025 Traffic Improves Year Over Year — Positive
LTM Zacks Investment Research — January 13, 2026LTM posts double-digit December 2025 traffic and capacity growth, adding new routes as passenger volumes rose across domestic and international markets.
Concentrix Corporation (CNXC) Q4 2025 Earnings Call Transcript — Neutral
CNXC Seeking Alpha — January 13, 2026Concentrix Corporation (CNXC) Q4 2025 Earnings Call Transcript
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to explain why she's buying more Chevron so soon.
Ampco-Pittsburgh Stock Surges 155.8% in 3 Months: What's Next? — Positive
AP Zacks Investment Research — January 13, 2026AP is leaning on ALP segment strength and pricing gains, but tariff risks and plant shutdowns pose headwinds.
CNI Achieves Robust Grain Performance Record in December — Positive
CNI Zacks Investment Research — January 13, 2026Canadian National posts a record 2.82M tonnes of grain moved in December, marking its fourth straight monthly high.
Will Apple (AAPL) Beat Estimates Again in Its Next Earnings Report? — Positive
AAPL Zacks Investment Research — January 13, 2026Apple (AAPL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Bank of America (BAC) Could Beat Earnings Estimates Again — Positive
BAC Zacks Investment Research — January 13, 2026Bank of America (BAC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Agnico (AEM) Beat Estimates Again in Its Next Earnings Report? — Positive
AEM Zacks Investment Research — January 13, 2026Agnico (AEM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Vertiv (VRT) Beat Estimates Again in Its Next Earnings Report? — Positive
VRT Zacks Investment Research — January 13, 2026Vertiv (VRT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Kinsale Capital Group (KNSL) Could Beat Earnings Estimates Again — Positive
KNSL Zacks Investment Research — January 13, 2026Kinsale Capital Group (KNSL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Ralph Lauren (RL) Beat Estimates Again in Its Next Earnings Report? — Positive
RL Zacks Investment Research — January 13, 2026Ralph Lauren (RL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Boot Barn (BOOT) Beat Estimates Again in Its Next Earnings Report? — Positive
BOOT Zacks Investment Research — January 13, 2026Boot Barn (BOOT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Fortinet (FTNT) Beat Estimates Again in Its Next Earnings Report? — Positive
FTNT Zacks Investment Research — January 13, 2026Fortinet (FTNT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
